NEO-CYT is a randomized, multi-centre trial of neoadjuvant MDNA11 (before curative intent surgery) sponsored by the Fondazione Melanoma Onlus, ...
Gross profit and gross margins were $19.8 million and 42%, respectively, in the third quarter of 2025, compared to $17.2 million and 41%, respectively, in the third quarter of 2024. The increase in ...
Asian shares have advanced, lifted by technology shares as they rebounded from last week's losses. South Korea's Kospi led the gains, jumping 3.5%. Computer chip maker SK Hynix, which is ...
Shares have bounced back in Asia after Wall Street got a boost from upbeat economic updates and a steady flow of quarterly ...
VANCOUVER, BC / ACCESS Newswire / November 11, 2025 / (TSX:NANO)(OTCQB:NNOMF)(Frankfurt:LBMB) Business Operational Highlights Newly installed proprietary agitator in full-scale One-Potâ„¢ reactor at ...
Get Q3 2025 insights on Mobile Infrastructure Corp (BEEP): revenue trends, asset sales, EV diversification, and future outlook.
The Memphis area is full of ways to ring in the holiday season with music, from concerts to the "Nutcracker" to ukuleles.
KedRAB Supply -- There is a "firm commitment to minimum orders for 2025 through 2027" with distribution agreement extended to ...
Q3 2025 Earnings Call Transcript November 10, 2025 Kamada Ltd. misses on earnings expectations. Reported EPS is $0.09199 EPS, ...
Good day, and thank you for standing by. Welcome to the Third Quarter 2025 Lincoln Educational Services Earnings Conference ...
Completed enrollment of the randomized Phase 1b cohorts of the ongoing ENABLE trial of ELVN-001 in CML Remains on track to initiate Phase 3 pivotal trial of ELVN-001 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results